Researches had indicated that ApoA1 levels can serve as a predictor of COVID-19 severity, with adequate levels potentially acting as a protective factor against severe outcomes (Ulloque-Badaracco et al., 2021; Zhu et al., 2021). This evidence concerns the gene APOA1 and COVID-19.